Saneca Pharmaceuticals made a net profit of EUR -3.60 mil in 2019, up 0% compared to the previous year. Total sales reached EUR 57.5 mil, which is up 60.6% when compared to the previous year.
Historically, between 2014 and 2019, the company’s net profit reached a high of EUR 6.60 mil in 2014 and a low of EUR -3.60 mil in 2019. Over the last decade the firm's net profit increased by an average of 0% a year.
Sales have fallen by 3.78% a year on average since 2014. They reached a high of EUR 69.7 mil in 2014 and a low of EUR 35.8 mil in 2018.
The company has been operating with an average EBITDA margin of 1.01% in the last 5 years and average net margin of -3.13%. The firm generated an average return on invested capital of -4.74% for its shareholders over the last five years.
You can see all the company’s data at Saneca Pharmaceuticals profile, or you can download a report on the company in the report section.
Helgi Library 
